Sign up
Pharma Capital

The Hydroponics Company new directors buy shares on market

The two directors purchased a combined $74,000+ worth of shares this week.
three empty boardroom seats
Shares in the company were last trading at 55 cents per share

The Hydroponics Company Ltd (ASX:THC) has received a vote of confidence from its two recently appointed board members, who have both recently purchased shares on market.

Lou Cattelan and Gary Radcliff were voted in by shareholders as directors of the board at an extraordinary general meeting (EGM) in March 2018.

Cattelan purchased $51,323 worth of shares at an average price of 58 cents through on-market trades this week.

Similarly, Radcliff purchased $23,369 worth of shares also through on-market trades this week.

READ: The Hydroponics Company recognises value in manufacturing facility

Radcliff is a barrister and is president of the Gold Coast Bar Association.

Cattelan is a pharmaceutical executive with over 30 years experience in technical and operations management in the pharmaceutical and related industries with organisations such as Vitaplex, Soul Pattinson, Wella and Blackmores.

View full THC profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.